UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Therapeutic drug monitoring in oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology consensus guidelines for imatinib therapy

European journal of cancer (1990), 2021-11, Vol.157, p.428-440

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetically Guided Dose Adjustment of 5-Fluorouracil: A Rational Approach to Improving Therapeutic Outcomes

JNCI : Journal of the National Cancer Institute, 2009-11, Vol.101 (22), p.1543-1552

2009

Link zum Volltext

Verfügbarkeit prüfen

Body-surface area-based chemotherapy dosing: appropriate in the 21st century?

Journal of clinical oncology, 2012-11, Vol.30 (31), p.3896-3897

2012

Link zum Volltext

Verfügbarkeit prüfen

Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice

Clinical colorectal cancer, 2016-12, Vol.15 (4), p.381-388

2016

Link zum Volltext

Verfügbarkeit prüfen

Project Confirm: Accelerated Drug Approvals for CML-Letter

Clinical cancer research, 2024-01, Vol.30 (1), p.235

2024

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: A randomized clinical trial of AUC‐guided dosing in nonsmall cell lung cancer

Clinical and translational medicine, 2021-04, Vol.11 (4), p.e354-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

New Immunoassays in Therapeutic Drug Monitoring: Where is the Journey Heading?

Therapeutic drug monitoring, 2023-02, Vol.45 (1), p.11

2023

Link zum Volltext

Verfügbarkeit prüfen

Randomized study of individualized pharmacokinetically‐guided dosing of paclitaxel compared with body‐surface area dosing in Chinese patients with advanced non‐small cell lung cancer

British journal of clinical pharmacology, 2019-10, Vol.85 (10), p.2292-2301

2019

Link zum Volltext

Verfügbarkeit prüfen

Point-of-care measurement of clozapine concentration using a finger-stick blood sample

Journal of psychopharmacology (Oxford), 2021-03, Vol.35 (3), p.279-283

2021

Link zum Volltext

Verfügbarkeit prüfen

Point of care assay for blood aripiprazole concentrations: development, validation and utility

British journal of psychiatry, 2023-08, Vol.223 (2), p.389-393

2023

Link zum Volltext

Verfügbarkeit prüfen

All Optimal Dosing Roads Lead to Therapeutic Drug Monitoring-Why Take the Slow Lane

JAMA oncology, 2022-12, Vol.8 (12), p.1733

2022

Link zum Volltext

Verfügbarkeit prüfen

An automated nanoparticle-based homogeneous immunoassay for determining docetaxel concentrations in plasma

Therapeutic drug monitoring, 2013-12, Vol.35 (6), p.803

2013

Link zum Volltext

Verfügbarkeit prüfen

Multicenter evaluation of a novel nanoparticle immunoassay for 5-fluorouracil on the Olympus AU400 analyzer

Therapeutic drug monitoring, 2009-12, Vol.31 (6), p.688

2009

Link zum Volltext

Verfügbarkeit prüfen

Excel-Based Tool for Pharmacokinetically Guided Dose Adjustment of Paclitaxel

Therapeutic drug monitoring, 2015-12, Vol.37 (6), p.725

2015

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel exposure-toxicity analysis reveals a pharmacokinetic determinant for dose-limiting neutropenia in East-Asian solid tumor patients: results from two prospective, phase II studies

Cancer chemotherapy and pharmacology, 2022-09, Vol.90 (3), p.229-237

2022

Link zum Volltext

Verfügbarkeit prüfen

Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements

Clinical chemistry and laboratory medicine, 2016-07, Vol.54 (7), p.1177

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a Nanoparticle-Based Busulfan Immunoassay for Rapid Analysis on Routine Clinical Analyzers

Therapeutic drug monitoring, 2021-12, Vol.43 (6), p.766

2021

Link zum Volltext

Verfügbarkeit prüfen

Validation of a Commercial Assay and Decision Support Tool for Routine Paclitaxel Therapeutic Drug Monitoring (TDM)

Therapeutic drug monitoring, 2017-12, Vol.39 (6), p.617

2017

Link zum Volltext

Verfügbarkeit prüfen

Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug Monitoring

Therapeutic drug monitoring, 2017-06, Vol.39 (3), p.235

2017

Link zum Volltext

Verfügbarkeit prüfen

An Automated Homogeneous Immunoassay for Quantitating Imatinib Concentrations in Plasma

Therapeutic drug monitoring, 2015-08, Vol.37 (4), p.486

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Excretion of Gamma-Hydroxybutyrate (GHB) in Healthy Subjects

Journal of analytical toxicology, 2004-11, Vol.28 (8), p.625-630

2004

Link zum Volltext

Verfügbarkeit prüfen

Development and evaluation of a nanoparticle-based immunoassay for determining paclitaxel concentrations on routine clinical analyzers

Therapeutic drug monitoring, 2013-12, Vol.35 (6), p.809

2013

Link zum Volltext

Verfügbarkeit prüfen

BIOMARKER STABILITY IN CSF: PRE-ANALYTICAL FACTORS IN A PROSPECTIVE COLLECTION

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P800-P800

2014

Link zum Volltext

Verfügbarkeit prüfen

Highlights from: 5-Fluorouracil Drug Management Pharmacokinetics and Pharmacogenomics Workshop; Orlando, Florida; January 2007

Clinical colorectal cancer, 2007-03, Vol.6 (6), p.407-422

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(65)
Dissertationen
(1)

Sprache

Englisch
(66)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapeutic drug monitoring in oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology consensus guidelines for imatinib therapy

Pharmacokinetically Guided Dose Adjustment of 5-Fluorouracil: A Rational Approach to Improving Therapeutic Outcomes

Body-surface area-based chemotherapy dosing: appropriate in the 21st century?

Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice

Project Confirm: Accelerated Drug Approvals for CML-Letter

Therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: A randomized clinical trial of AUC‐guided dosing in nonsmall cell lung cancer

New Immunoassays in Therapeutic Drug Monitoring: Where is the Journey Heading?

Randomized study of individualized pharmacokinetically‐guided dosing of paclitaxel compared with body‐surface area dosing in Chinese patients with advanced non‐small cell lung cancer

Point-of-care measurement of clozapine concentration using a finger-stick blood sample

Point of care assay for blood aripiprazole concentrations: development, validation and utility

All Optimal Dosing Roads Lead to Therapeutic Drug Monitoring-Why Take the Slow Lane

An automated nanoparticle-based homogeneous immunoassay for determining docetaxel concentrations in plasma

Multicenter evaluation of a novel nanoparticle immunoassay for 5-fluorouracil on the Olympus AU400 analyzer

The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau

Excel-Based Tool for Pharmacokinetically Guided Dose Adjustment of Paclitaxel

Paclitaxel exposure-toxicity analysis reveals a pharmacokinetic determinant for dose-limiting neutropenia in East-Asian solid tumor patients: results from two prospective, phase II studies

Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements

Evaluation of a Nanoparticle-Based Busulfan Immunoassay for Rapid Analysis on Routine Clinical Analyzers

Validation of a Commercial Assay and Decision Support Tool for Routine Paclitaxel Therapeutic Drug Monitoring (TDM)

Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug Monitoring

An Automated Homogeneous Immunoassay for Quantitating Imatinib Concentrations in Plasma

Pharmacokinetics and Excretion of Gamma-Hydroxybutyrate (GHB) in Healthy Subjects

Development and evaluation of a nanoparticle-based immunoassay for determining paclitaxel concentrations on routine clinical analyzers

BIOMARKER STABILITY IN CSF: PRE-ANALYTICAL FACTORS IN A PROSPECTIVE COLLECTION

Highlights from: 5-Fluorouracil Drug Management Pharmacokinetics and Pharmacogenomics Workshop; Orlando, Florida; January 2007

Suchergebnisse filtern